Go to journal home page - Drug Discovery Today

Drug Discovery Today

Volume 23, Issue 11

Pages 1807-1918 (November 2018)

Actions for selected articles

/

Contents

    1. Contents page 1

      Page i
      View PDF
    1. Contents page 2

      Page ii
      View PDF
  1. Editorial

    1. Is the independence of medical research at stake? On the forces shaping the research agenda

      Pages 1807-1808
    2. Biobanks: let’s share specimens

      Pages 1809-1811
  2. Perspective

    1. Feature

      1. Translational strategy: humanized mini-organs

        Pages 1812-1817
      2. Why breast cancer signatures are no better than random signatures explained

        Pages 1818-1823
  3. REVIEWS

    1. Keynote

      1. Recommendations toward a human pathway-based approach to disease research

        Pages 1824-1832
        View PDF
      2. The A–Z of Zika drug discovery

        Pages 1833-1847
        View PDF
      3. Discovering novel valid biomarkers and drugs in patient-centric genomic trials: the new epoch of precision surgical oncology

        Pages 1848-1872
    2. Gene to Screen

      1. Prolyl hydroxylase 2: a promising target to inhibit hypoxia-induced cellular metabolism in cancer cells

        Pages 1873-1882
      2. Mapping genes for drug chronotherapy

        Pages 1883-1888
    3. Informatics

      1. Selection of protein conformations for structure-based polypharmacology studies

        Pages 1889-1896
    4. Post Screen

      1. Delivery systems of local anesthetics in bone surgery: are they efficient and safe?

        Pages 1897-1903
      2. Why are there no drugs indicated for sciatica, the most common chronic neuropathic syndrome of all?

        Pages 1904-1909
      3. Small-molecule inhibitors of macrophage migration inhibitory factor (MIF) as an emerging class of therapeutics for immune disorders

        Pages 1910-1918

ISSN: 1359-6446